Tilray
TLRY
About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Employees: 2,842
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0.36% more ownership
Funds ownership: 9.81% [Q1] → 10.17% (+0.36%) [Q2]
2% less call options, than puts
Call options by funds: $4.2M | Put options by funds: $4.28M
6% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 77
4% less funds holding
Funds holding: 327 [Q1] → 313 (-14) [Q2]
23% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 52
29% less capital invested
Capital invested by funds: $60.4M [Q1] → $42.8M (-$17.6M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Jefferies
Kaumil Gajrawala
|
$2
|
Buy
Maintained
|
25 Aug 2025 |
Financial journalist opinion
Based on 26 articles about TLRY published over the past 30 days